glutathione conjugate transporter Metabolism of S-Conjugates: Multiple Pathways Phase II - Glutathione Conjugation
Description
Updated June 26, 2025
Signs you may need to reduce dose include persistent headaches, unusual fatigue, or injection site reactions that worsen over time
Signal Transduct Target Ther 991):234
Copper tripeptide-1: chemical and biological data
